Pharmaceutical

Profit for Divi Labs’ Q1 increased by 26% to Rs. 702 crores

Revenue from operations at Divis Laboratories increased by around 15% YoY to 2,254 crore.

IT Department raids pharma manufacturers in Haryana, Delhi-NCR, seizes Rs 4.2 crore cash

Income Tax Department raided pharmaceutical manufacturers & distributors in Haryana and Delhi-NCR and seized cash of Rs 4.2 crore.

Piramal Enterprise searching acquisition opportunities in multiple pharma asset

COVID-19 Vaccine: India’s Panacea Biotec aims to produce 100 million doses of Sputnik V annually

Production of Sputnik V at Panacea Biotec sites will help facilitate global supply of Sputnik V to international partners of RDIF.

Glenmark Pharmaceutical reports 30.04% rise in net profits for Q3

Sensex gained 792 points, Nifty surged above 15,100

Sun Pharma Q3 reports two fold jump in net profit

Pharma index rises to 5-year-high at Rs 12,636

Carlyle Group to acquire Granules India for $1 billion: Source

Gland Pharma all set to release biggest pharma IPO in India

Also, Citigroup, Haitong Securities, Kotak Mahindra Bank and Nomura Holdings are managing the deal.

Market Closing: Indices close red, Pharma outperforms

On market closing the indices closed with negative bias also not much action in the markets was noticed on the last trading day of the week, Pharma stocks performed well with Cipla bagging the top gainer of Nifty.